Discovery, Chemistry, and Preclinical Development of Pritelivir, a Novel Treatment Option for Acyclovir-Resistant Herpes Simplex Virus Infections

[Image: see text] When the nucleoside analogue acyclovir was introduced in the early 1980s, it presented a game-changing treatment modality for herpes simplex virus infections. Since then, work has been ongoing to improve the weaknesses that have now been identified: a narrow time window for therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Birkmann, Alexander, Bonsmann, Susanne, Kropeit, Dirk, Pfaff, Tamara, Rangaraju, Manickam, Sumner, Melanie, Timmler, Burkhard, Zimmermann, Holger, Buschmann, Helmut, Ruebsamen-Schaeff, Helga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620171/
https://www.ncbi.nlm.nih.gov/pubmed/36202389
http://dx.doi.org/10.1021/acs.jmedchem.2c00668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620171/
https://www.ncbi.nlm.nih.gov/pubmed/36202389
http://dx.doi.org/10.1021/acs.jmedchem.2c00668

Ejemplares similares